Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation

  1. Kenichi Nishioka1,
  2. Sergei Chuikov1,
  3. Kavitha Sarma1,
  4. Hediye Erdjument-Bromage2,
  5. C. David Allis3,
  6. Paul Tempst2, and
  7. Danny Reinberg1,4
  1. 1Howard Hughes Medical Institute, Division of Nucleic Acids Enzymology, Department of Biochemistry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA; 2Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA; 3University of Virginia, Department of Biochemistry & Molecular Genetics, University of Virginia Health System, Charlottesville, Virginia 22908-0733, USA

Abstract

A novel histone methyltransferase, termed Set9, was isolated from human cells. Set9 contains a SET domain, but lacks the pre- and post-SET domains. Set9 methylates specifically lysine 4 (K4) of histone H3 (H3-K4) and potentiates transcription activation. The histone H3 tail interacts specifically with the histone deacetylase NuRD complex. Methylation of histone H3-K4 by Set9 precludes the association of NuRD with the H3 tail. Moreover, methylation of H3-K4 impairs Suv39h1-mediated methylation at K9 of H3 (H3-K9). The interplay between the Set9 and Suv39h1 histone methyltransferases is specific, as the methylation of H3-K9 by the histone methyltransferase G9a was not affected by Set9 methylation of H3-K4. Our studies suggest that Set9-mediated methylation of H3-K4 functions in transcription activation by competing with histone deacetylases and by precluding H3-K9 methylation by Suv39h1. Our results suggest that the methylation of histone tails can have distinct effects on transcription, depending on its chromosomal location, the combination of posttranslational modifications, and the enzyme (or protein complex) involved in the particular modification.

Keywords

Footnotes

  • 4 Corresponding author.

  • E-MAIL reinbedf{at}umdnj.edu; FAX (732) 235-5294.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.967202.

    • Received December 4, 2001.
    • Accepted December 27, 2001.
| Table of Contents

Life Science Alliance